Eledon Pharmaceuticals (ELDN) Profit After Tax (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Profit After Tax of -$39.0 million for Q1 2026, down 500.85% year-on-year from $9.7 million in Q1 2025, and down 274.63% on a QoQ basis from -$10.4 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Profit After Tax data on file, last reported at -$39.0 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 500.85% year-over-year to -$39.0 million; the trailing twelve-month figure through Mar 2026 stood at -$78.1 million (down 310.11% YoY), and the FY2025 full-year result was -$45.6 million, down 26.07% from the prior year.
- Profit After Tax for Q1 2026 stood at -$39.0 million, down from -$10.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at $77.0 million in Q3 2024 and bottomed at -$65.8 million in Q2 2023.
- The 5-year median for Profit After Tax is -$11.2 million (2025), against an average of -$19.1 million.
- The widest annual swing landed in 2023, when Profit After Tax plunged 611.15%; it then soared 877.01% in 2024.
- A 5-year view of Profit After Tax shows it stood at -$58.4 million in 2022, then soared by 48.45% to -$30.1 million in 2023, then sank by 48.23% to -$44.6 million in 2024, then jumped by 76.65% to -$10.4 million in 2025, then plunged by 274.63% to -$39.0 million in 2026.
- The last three Profit After Tax figures came in at -$39.0 million (Q1 2026), -$10.4 million (Q4 2025), and -$17.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | -39.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.03 Mn |
| Dec 31, 2025 | -10.42 Mn |
| Sep 30, 2025 | -17.46 Mn |
| Jun 30, 2025 | -11.22 Mn |
| Mar 31, 2025 | -6.50 Mn |
| Dec 31, 2024 | -44.62 Mn |
| Sep 30, 2024 | 76.97 Mn |
| Jun 30, 2024 | -44.91 Mn |
| Mar 31, 2024 | -23.63 Mn |
| Dec 31, 2023 | -30.10 Mn |
| Sep 30, 2023 | -9.91 Mn |
| Jun 30, 2023 | -65.76 Mn |
| Mar 31, 2023 | -10.77 Mn |
| Dec 31, 2022 | -58.38 Mn |
| Sep 30, 2022 | -10.47 Mn |
| Jun 30, 2022 | -9.25 Mn |
| Mar 31, 2022 | -9.86 Mn |
| Dec 31, 2021 | -8.81 Mn |
| Sep 30, 2021 | -9.82 Mn |
| Jun 30, 2021 | -7.38 Mn |
| Mar 31, 2021 | -8.50 Mn |
| Dec 31, 2020 | -5.90 Mn |
| Sep 30, 2020 | -6.14 Mn |
| Jun 30, 2020 | -2.59 Mn |
| Mar 31, 2020 | -8.18 Mn |
| Dec 31, 2019 | -4.14 Mn |
| Sep 30, 2019 | -2.89 Mn |
| Jun 30, 2019 | -4.09 Mn |
| Mar 31, 2019 | -4.88 Mn |
| Dec 31, 2018 | -4.57 Mn |
| Sep 30, 2018 | -3.50 Mn |
| Jun 30, 2018 | -3.19 Mn |
| Mar 31, 2018 | -2.81 Mn |
| Dec 31, 2017 | -2.11 Mn |
| Sep 30, 2017 | -2.97 Mn |
| Jun 30, 2017 | -6.66 Mn |
| Mar 31, 2017 | -1.37 Mn |
| Dec 31, 2016 | -3.74 Mn |
| Sep 30, 2016 | -2.04 Mn |
| Jun 30, 2016 | -1.00 Mn |
| Mar 31, 2016 | -11.43 Mn |
| Dec 31, 2015 | -11.02 Mn |
| Sep 30, 2015 | -11.85 Mn |
| Jun 30, 2015 | -8.96 Mn |
| Mar 31, 2015 | -13.26 Mn |
| Dec 31, 2014 | -6.21 Mn |
| Sep 30, 2014 | -6.39 Mn |
| Jun 30, 2014 | -5.85 Mn |
| Mar 31, 2014 | -4.85 Mn |
| Dec 31, 2013 | -5.53 Mn |
| Sep 30, 2013 | -3.37 Mn |